{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:40:30Z","timestamp":1789756830790,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1378\/chest.12-1763","type":"journal-article","created":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T09:56:42Z","timestamp":1361440602000},"page":"215-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Phase 3 Randomized Study of the Efficacy and Safety of Inhaled Dry Powder Mannitol for the Symptomatic Treatment of Non-Cystic Fibrosis Bronchiectasis"],"prefix":"10.1016","volume":"144","author":[{"given":"Diana","family":"Bilton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Daviskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra D.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kolbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob G.","family":"Stirling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Milne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Charlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1018","key":"10.1378\/chest.12-1763_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/pgmj.2009.091041","article-title":"Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century","volume":"86","author":"Goeminne","year":"2010","journal-title":"Postgrad Med J"},{"issue":"4","key":"10.1378\/chest.12-1763_bib2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.rmed.2007.11.007","article-title":"Bronchiectasis in Central Australia: a young face to an old disease","volume":"102","author":"Steinfort","year":"2008","journal-title":"Respir Med"},{"issue":"7","key":"10.1378\/chest.12-1763_bib3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/adc.2004.066472","article-title":"New Zealand national incidence of bronchiectasis \u201ctoo high\u201d for a developed country","volume":"90","author":"Twiss","year":"2005","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1378\/chest.12-1763_bib4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ppul.10289","article-title":"Non-CF bronchiectasis: clinical and HRCT evaluation","volume":"35","author":"Chang","year":"2003","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1378\/chest.12-1763_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.cpm.0000171422.98696.ed","article-title":"Prevalence and economic burden of bronchiectasis","volume":"12","author":"Weycker","year":"2005","journal-title":"Clin Pulm Med"},{"issue":"6","key":"10.1378\/chest.12-1763_bib6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5694\/j.1326-5377.2010.tb03949.x","article-title":"Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand","volume":"193","author":"Chang","year":"2010","journal-title":"Med J Aust"},{"issue":"suppl 1","key":"10.1378\/chest.12-1763_bib7","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thx.2010.136119","article-title":"British Thoracic Society guideline for non-CF bronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax"},{"key":"10.1378\/chest.12-1763_bib8","first-page":"239","article-title":"Pharmacological airway clearance strategies in bronchiectasis","volume":"52","author":"Bye","year":"2011","journal-title":"European Respiratory Monograph"},{"issue":"1","key":"10.1378\/chest.12-1763_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1440-1843.2005.00659.x","article-title":"Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum","volume":"10","author":"Daviskas","year":"2005","journal-title":"Respirology"},{"issue":"5","key":"10.1378\/chest.12-1763_bib10","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1183\/09031936.00187510","article-title":"Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study","volume":"38","author":"Bilton","year":"2011","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1378\/chest.12-1763_bib11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1164\/rccm.201109-1666OC","article-title":"Long-term inhaled mannitol in cystic fibrosis: an international randomized study","volume":"185","author":"Aitken","year":"2012","journal-title":"Am J Resp Crit Care Med"},{"issue":"suppl 48","key":"10.1378\/chest.12-1763_bib12","first-page":"707","article-title":"A placebo controlled trial with inhaled mannitol improves health related quality of life in patients with bronchiectasis","volume":"24","author":"Daviskas","year":"2004","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1378\/chest.12-1763_bib13","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.rmed.2011.12.021","article-title":"The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis","volume":"106","author":"Nicolson","year":"2012","journal-title":"Respir Med"},{"issue":"12","key":"10.1378\/chest.12-1763_bib14","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.rmed.2011.07.019","article-title":"Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis","volume":"105","author":"Kellett","year":"2011","journal-title":"Respir Med"},{"issue":"3","key":"10.1378\/chest.12-1763_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa043900","article-title":"A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis","volume":"354","author":"Elkins","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1378\/chest.12-1763_bib16","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1164\/ajrccm.159.6.9809074","article-title":"Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis","volume":"159","author":"Daviskas","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1378\/chest.12-1763_bib17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.rmed.2009.10.021","article-title":"Effect of mannitol and repetitive coughing on the sputum properties in bronchiectasis","volume":"104","author":"Daviskas","year":"2010","journal-title":"Respir Med"},{"issue":"2","key":"10.1378\/chest.12-1763_bib18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1378\/chest.119.2.414","article-title":"The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis","volume":"119","author":"Daviskas","year":"2001","journal-title":"Chest"},{"issue":"3","key":"10.1378\/chest.12-1763_bib19","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1034\/j.1399-3003.1999.14c30.x","article-title":"The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study","volume":"14","author":"Robinson","year":"1999","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1378\/chest.12-1763_bib20","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1440-1843.2007.01107.x","article-title":"Inhaled mannitol changes the sputum properties in asthmatics with mucus hypersecretion","volume":"12","author":"Daviskas","year":"2007","journal-title":"Respirology"},{"issue":"suppl 48","key":"10.1378\/chest.12-1763_bib21","first-page":"470s","article-title":"Inhaled mannitol improves lung function assessed by forced oscillation in a placebo-controlled trial in patients with bronchiectasis [abstract]","volume":"24","author":"Goldman","year":"2004","journal-title":"Eur Resp J"},{"key":"10.1378\/chest.12-1763_bib22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1465-9921-6-144","article-title":"The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline","volume":"6","author":"Brannan","year":"2005","journal-title":"Respir Res"},{"issue":"2","key":"10.1378\/chest.12-1763_bib23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1479972306075483","article-title":"Acapella versus \u2018usual airway clearance\u2019 during acute exacerbation in bronchiectasis: a randomized crossover trial","volume":"4","author":"Patterson","year":"2007","journal-title":"Chron Respir Dis"},{"issue":"2","key":"10.1378\/chest.12-1763_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"issue":"suppl 16","key":"10.1378\/chest.12-1763_bib25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09041950.005s1693","article-title":"Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung FunctionTests, European Community for Steel and Coal. Official Statement of the European Respiratory Society","volume":"6","author":"Quanjer","year":"1993","journal-title":"Eur Respir J"},{"issue":"suppl B","key":"10.1378\/chest.12-1763_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0954-6111(06)80166-6","article-title":"The St George's Respiratory Questionnaire","volume":"85","author":"Jones","year":"1991","journal-title":"Respir Med"},{"issue":"4","key":"10.1378\/chest.12-1763_bib27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/thorax.58.4.339","article-title":"Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)","volume":"58","author":"Birring","year":"2003","journal-title":"Thorax"},{"issue":"10","key":"10.1378\/chest.12-1763_bib28","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis","volume":"331","author":"Fuchs","year":"1994","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1378\/chest.12-1763_bib29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/thorax.55.3.198","article-title":"Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests","volume":"55","author":"Roberts","year":"2000","journal-title":"Thorax"},{"issue":"2 pt 1","key":"10.1378\/chest.12-1763_bib30","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1164\/ajrccm.161.2.9812073","article-title":"An analysis algorithm for measuring airway lumen and wall areas from high-resolution computed tomographic data","volume":"161","author":"King","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1378\/chest.12-1763_bib31","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/thx.47.12.1019","article-title":"Development of a shuttle walking test of disability in patients with chronic airways obstruction","volume":"47","author":"Singh","year":"1992","journal-title":"Thorax"},{"issue":"1","key":"10.1378\/chest.12-1763_bib32","first-page":"75","article-title":"George's Respiratory Questionnaire: MCID COPD","volume":"2","author":"St Jones","year":"2005","journal-title":"J of Chronic Obst Pulm Dis"},{"issue":"7","key":"10.1378\/chest.12-1763_bib33","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1517\/13543784.16.7.1121","article-title":"Inhaled mannitol in cystic fibrosis","volume":"16","author":"Wills","year":"2007","journal-title":"Expert Opin Investig Drugs"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369213604705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369213604705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:36:40Z","timestamp":1757918200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369213604705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0012369213604705"],"URL":"https:\/\/doi.org\/10.1378\/chest.12-1763","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase 3 Randomized Study of the Efficacy and Safety of Inhaled Dry Powder Mannitol for the Symptomatic Treatment of Non-Cystic Fibrosis Bronchiectasis","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.12-1763","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}